Hematology Analyzers and Reagents Market Report 2026

Hematology Analyzers and Reagents Market Overview

• Hematology Analyzers and Reagents market size has reached to $5.25 billion in 2025 • Expected to grow to $7.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Rising Prevalence Of Blood Disorders Driving Growth In Hematology Analyzers And Reagents Market • Market Trend: Advancements In Automated Hematology Platforms • North America was the largest region in 2025 and Western Europe is the fastest growing region.

What Is Covered Under Hematology Analyzers and Reagents Market?

Hematology analyzers provide complete blood count (CBC) with a three-part differential white blood cell (WBC) count and can detect small cell populations to diagnose rare blood conditions, and measure cell morphology. The main products in hematology analyzers and reagents are hematology analyzers, hemostasis analyzers, plasma protein analyzers, hemoglobin analyzers, erythrocyte sedimentation rate analyzers, coagulation analyzers, flow cytometers, slide stainers, differential counters, and hematology stains. The hematology analyzers are devices that measure the concentration of hemoglobin in a blood sample. The various applications include anemias, blood cancers, hemorrhagic conditions, infection-related conditions, immune system-related conditions, and others that are used by end-users such as specialized research institutes, hospitals, specialized diagnostic centers, and others.

What Is The Hematology Analyzers and Reagents Market Growth Forecast?

The hematology analyzers and reagents market size is expected to see strong growth in the next few years. It will grow to $7.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to integration of AI-based cell analysis, rising adoption of fully automated hematology systems, growing focus on precision medicine and personalized diagnostics, expansion of diagnostic centers in emerging markets, increasing demand for advanced reagents and consumables. Major trends in the forecast period include rising adoption of automated and high-throughput hematology analyzers, growing demand for accurate and early diagnosis of blood disorders, increasing use of point-of-care hematology testing, expansion of reagent rental and consumable-based business models, enhanced focus on standardization and quality control in hematology testing.

Global Hematology Analyzers and Reagents Market Segmentation

1) By Product: Hematology Analyzers, Hemostasis Analyzers, Plasma Protein Analyzers, Hemoglobin Analyzers, Erythrocyte Sedimentation Rate Analyzer, Coagulation Analyzer 2) By Applications: Anemias, Blood Cancers, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, Other Applications 3) By End User: Specialized Research Institutes, Hospitals, Specialized Diagnostic Centers, Other End Users Subsegments: 1) By Hematology Analyzers: Automated Hematology Analyzers, Semi-Automated Hematology Analyzers 2) By Hemostasis Analyzers: Platelet Function Analyzers, Coagulation Testing Analyzers 3) By Plasma Protein Analyzers: Electrophoresis Analyzers, Immunofixation Analyzers 4) By Hemoglobin Analyzers: Point-Of-Care Hemoglobin Analyzers, Laboratory Hemoglobin Analyzers 5) By Erythrocyte Sedimentation Rate Analyzer: Manual ESR Analyzers, Automated ESR Analyzers 6) By Coagulation Analyzer: Clotting Time Analyzers, Thromboelastography (TEG) Analyzers

What Is The Driver Of The Hematology Analyzers and Reagents Market?

The rise in the prevalence of blood disorders is expected to drive the growth of the hematology analyzers and reagents market going forward. A blood disorder is a medical condition that affects the normal functioning of blood components, such as red blood cells, white blood cells, or platelets. Hematology analyzers and reagents are crucial tools for diagnosing and monitoring blood disorders, including cancer, by analyzing blood cell counts and morphology. For instance, in July 2024, according to Cancer Research UK, a UK-based charity, the average number of new Hodgkin lymphoma cases per year in the UK is expected to increase from approximately 2,400 cases in 2023-2025 to around 2,900 cases in 2038-2040. As a result, the rise in the prevalence of blood disorders is propelling the hematology analyzers and reagents industry forward.

Key Players In The Global Hematology Analyzers and Reagents Market

Major companies operating in the hematology analyzers and reagents market are Abbott Laboratories, Bio-Rad Laboratories, Horiba Ltd., Siemens AG, Sysmex Corporation, BioSystems Diagnostics Pvt. Ltd, Boule Diagnostics, Danaher Corporation, Diatron MI PLC, Drew Scientific, EKF Diagnostics, Mindray, Nihon Kohden, Ortho Clinical Diagnostics, Roche, Beckman Coulter, Bayer AG, Heska, Drucker, Instrumentation Laboratory, Abaxis Inc., Accriva Diagnostics, ACON, Diamond Diagnostics, ERBA Diagnostics, Hycel, Maccura Biotechnology Co. Ltd., Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS

Global Hematology Analyzers and Reagents Market Trends and Insights

Major companies operating in the hematology analyzers and reagents market are focusing on developing innovative solutions, such as automated hematology platform, to enhance diagnostic accuracy, streamline laboratory workflows, and provide more comprehensive patient data. An automated hematology platform (often called a hematology analyzer) is a sophisticated, computer-driven medical laboratory instrument designed to perform a complete blood count (CBC) and other related tests on a blood sample rapidly, accurately, and with minimal human intervention. For instance, in January 2024, HORIBA Medical, a France-based in vitro diagnostics company, launched the Yumizen Helo, a next-generation, fully automated and modular hematology solution. This system integrates a high-throughput analyzer with a digital cell morphology module and an automated reticulocyte module into a single, compact unit. Its key feature is walkaway automation, which uses an intelligent robotic arm to automatically sort and prepare blood smears, significantly reducing manual steps and operator intervention compared to traditional benchtop analyzers that require separate, manual processes for slide preparation and review. This innovation is designed to boost productivity in clinical laboratories by consolidating multiple hematology tasks into one continuous, automated workflow.

What Are Latest Mergers And Acquisitions In The Hematology Analyzers and Reagents Market?

In January 2024, Fujirebio Holdings, a Japan-based diagnostics company, partnered with Agappe Diagnostics Ltd. With this partnership, they seek to collaborate on the development of advanced diagnostic technologies and expand their product offerings in the global healthcare market. Agappe Diagnostics Ltd. is an India-based diagnostics company that specializes in developing and manufacturing a wide range of innovative diagnostic solutions.

Regional Outlook

North America was the largest region in the hematology analyzers and reagents market in 2025. Western Europe was the second-largest region in the hematology analyzers and reagents market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Hematology Analyzers and Reagents Market?

The hematology analyzers and reagents market consists of sales electrolyte analyzers, hemocoagulometer, enzyme standard instruments, blood gas analyzers and immunoturbidimetry. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.